AASLD 2021: In Advanced HCC, Molecular Markers Are Identified of Response to Anti-PD1 Therapy
Pre-immunotherapy biopsy can identify biomarkers of response.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.